A Republican bill with 1 Democratic cosponsor · See the cosponsor
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The Prescription Information Modernization Act of 2026 aims to allow the prescribing information for drugs and biological products to be provided solely through electronic means. Under this bill, manufacturers can move to digital-only labeling as long as they follow the law. Manufacturers must still let prescribers and dispensers choose to receive paper versions or request them as needed at no extra cost. The Secretary of Health and Human Services is tasked with issuing final regulations and minimizing economic impacts on those providing the medicine. Additionally, a public workshop will be held to discuss the usability and accessibility of this information.
Yes
- Scored +1
Does this make health care easier to get in general?
The bill modernizes access to drug information through digital channels while maintaining paper options.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Electronic Access to Information: Manufacturers may make required prescribing information available solely by electronic means, which could modernize how information is shared (Section 2(a)).
-
Choice of Format: Prescribers and dispensers are given the opportunity to elect to continue receiving information in paper form (Section 2(a)).
-
Cost Protection for Paper Requests: If a prescriber or dispenser requests paper labeling on an as-needed basis, the manufacturer must provide it promptly without any additional cost (Section 2(a)).
-
Economic Safeguards: The Secretary of Health and Human Services is required to design regulations that minimize adverse economic impacts on prescribers and dispensers (Section 2(b)(2)).
Potential Negative Impacts for People
- Shift to Digital-Only Labeling: Required prescribing information for drugs subject to section 503(b)(1) may be made available solely by electronic means, which moves away from traditional paper documentation (Section 2(a)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make health care easier to get in general? — The bill modernizes access to drug information through digital channels while maintaining paper options.
- 8/4/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 1 Cosponsor added.
- Introduced in Senate
5 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Cory BookerDemocrat · New Jersey